Loading...
Please wait, while we are loading the content...
miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1.
| Content Provider | Europe PMC |
|---|---|
| Author | Li, Yuan Hua, Kaiyao Jin, Jiali Fang, Lin |
| Copyright Year | 2021 |
| Abstract | MicroRNA (miR)-497 has been reported as a tumor suppressor in various cancer types. Nonetheless, the regulation of triple-negative breast cancer (TNBC) by miR-497 remains poorly understood. The present study aimed to investigate the potential function and mechanism of miR-497 in TNBC. A total of 36 TNBC and matched non-cancerous tissue samples were collected for analysis. Reverse transcription-quantitative PCR was performed to detect the miR-497 levels in TNBC tissue. The association between miR-497 expression, clinical characteristics and survival was then analyzed. To investigate the role of miR-497 in TNBC, MTT, colony formation, Transwell invasion, cell cycle and cell apoptosis assays were conducted following transfection of miR-497 mimics into the MDA-MB-231 and MDA-MB-468 cell lines. Luciferase reporter assays and western blot analysis were used to confirm the regulation of a putative target of miR-497. The results indicated that the expression of miR-497 was downregulated in the TNBC specimens. Further analysis demonstrated that the expression of miR-497 was downregulated in patients with advanced TNBC stages and that low miR-497 was associated with poor prognosis in patients with TNBC. Transfection of miR-497 mimics inhibited TNBC cell proliferation and increased cell apoptosis in MDA-MB-231 and MDA-MB-468 cells. Moreover, cell migration was inhibited following overexpression of miR-497, which also led to the arrest of the breast cancer cells in the G0/G1 phase of the cell cycle. Yes-associated protein 1 (YAP1), a critical molecule in the Hippo pathway, was identified as a target of miR-497. Notably, the protein and mRNA expression levels of YAP1 in MDA-MB-231 and MDA-MB-468 cells were downregulated following overexpression of miR-497. Overall, the findings of the present study indicated that miR-497 inhibited TNBC cell proliferation and migration and induced cell apoptosis by negatively regulating YAP1 expression. Thus, targeting miR-497 may represent a potential strategy for the treatment of TNBC. |
| ISSN | 17921074 |
| Journal | Oncology Letters |
| Volume Number | 22 |
| PubMed Central reference number | PMC8190776 |
| Issue Number | 2 |
| PubMed reference number | 34122631 |
| e-ISSN | 17921082 |
| DOI | 10.3892/ol.2021.12841 |
| Language | English |
| Publisher | D.A. Spandidos |
| Publisher Date | 2021-06-02 |
| Access Restriction | Open |
| Rights License | This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Copyright: © Li et al. |
| Subject Keyword | microRNA-497 breast cancer; YAP1 proliferation metastasis |
| Content Type | Text |
| Resource Type | Article |
| Subject | Cancer Research Oncology |